Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices

British Journal of Clinical Pharmacology

Volumn 46, Issue 1, 1998, Pages 45-48

  Lipworth, B J ^a   Clark, D J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Lung delivery; Non CFC metered dose inhaler; Salbutamol; Small and large volume plastic spacers

Indexed keywords

SALBUTAMOL SULFATE;

ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; INTERMETHOD COMPARISON; METERED DOSE INHALER; PRIORITY JOURNAL;

ABSORPTION; ADMINISTRATION, INHALATION; ADULT; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; EQUIPMENT DESIGN; FEMALE; HUMANS; LUNG; MALE; NEBULIZERS AND VAPORIZERS; SINGLE-BLIND METHOD;

EID: 0031831738     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00041.x     Document Type: Article

References (21)

1. Crornpton GK. Problems patients have using pressurised aerosol inhalers. Eur J Respir Dis 1982; 63(Suppl 119): 101-104.
2. Pedersen S. Choice of inhalation therapy in asthmatics. Eur Respir Rev 1994; 4: 86-89.
3. Siafakas NM, Bouros D. Choice of inhalation therapy in adults. Eur Respir Rev 1994; 4: 78-81.
4. Konig P. Spacer devices used with metered dose inhalers. Breakthrough or gimmick? Chest 1985; 88: 276-284.
5. Newman SP, Millar AB, Lennard-Jones TR, Moren F, Clarke SW. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax 1984; 39: 935-941.
6. Tobin M, Jenouri G, Danta I, Kim C, Watson H, Sackner M. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems. Am Rev Respir Dis 1982; 126: 670-675.
7. Cushley M, Lewis R, Tattersfield A. Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax 1983; 38: 908-913.
8. Lipworth BJ, Clark RA, Dhillon DP, et al. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol 1989; 37: 567-571.
9. Chrystyn H, Corlett SA, Silkstone V. Lung bioavailability of generic and innovator salbutamol MDIs. Thorax 1996; 51: 658.
10. Lipworth BJ. Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol 1996; 42: 697-705.
11. Clark DJ, Lipworth BJ. Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol. Br J Clin Pharmacol 1996; 41: 247-249.
12. Clark DJ, Lipworth BJ. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device. Thorax 1996; 51: 981-984.
13. Clark DJ, Gordon-Smith J, McPhate G, Clark G, Lipworth BJ. Lung bioavailability of generic and innovator salbutamol metered dose inhalers. Thorax 1996; 51: 325-326.
14. Lipworth BJ, McDevitt DG. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol 1989; 36: 239-245.
15. Newnham DM, Lipworth BJ. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser system (Ventstream). Thorax 1994; 49: 762-770.
16. Hindle M, Chrystyn H. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices. Thorax 1994; 49: 549-553.
17. Berg E. In vitro properties of pressurised metered dose inhalers with and without spacer devices. J Aerosol Med 1995; 8(Suppl 3), S3-:10.
18. Purewal TS, Patel N, Warren DA. The non-CFC metered dose inhaler performance with a spacer device. Thorax 1996; 51(Suppl 3), A: 75.
19. Dolovich M, Eng P, Ruffin R, Corr D, Newhouse MT. Clinical evaluation of a simple demand inhalation aerosol delivery device. Chest 1983; 84: 36-41.
20. Gurwitz D, Levison H, Mindorff C, Reilly P, Worsley G. Assessment of a new device (Aerochamber) for use with aerosol drugs in asthmatic children. Ann Allergy 1983; 50: 166-170.
21. Barry PW, O'Callaghan C. Inhalational drug delivery from seven different spacer devices. Thorax 1996; 51: 835-840.